Logo image of TIVC

TIVIC HEALTH SYSTEMS INC (TIVC) Stock Fundamental Analysis

NASDAQ:TIVC - Nasdaq - US8887053085 - Common Stock - Currency: USD

3.2  -0.01 (-0.31%)

After market: 3.32 +0.12 (+3.75%)

Fundamental Rating

2

Overall TIVC gets a fundamental rating of 2 out of 10. We evaluated TIVC against 187 industry peers in the Health Care Equipment & Supplies industry. The financial health of TIVC is average, but there are quite some concerns on its profitability. TIVC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year TIVC has reported negative net income.
TIVC had negative earnings in each of the past 5 years.
TIVC had a negative operating cash flow in each of the past 5 years.
TIVC Yearly Net Income VS EBIT VS OCF VS FCFTIVC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

TIVC has a Return On Assets of -150.28%. This is amonst the worse of the industry: TIVC underperforms 88.24% of its industry peers.
TIVC has a Return On Equity of -186.96%. This is in the lower half of the industry: TIVC underperforms 72.73% of its industry peers.
Industry RankSector Rank
ROA -150.28%
ROE -186.96%
ROIC N/A
ROA(3y)-177.89%
ROA(5y)-165.61%
ROE(3y)-243.86%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TIVC Yearly ROA, ROE, ROICTIVC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600 -800

1.3 Margins

TIVC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TIVC Yearly Profit, Operating, Gross MarginsTIVC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

5

2. Health

2.1 Basic Checks

TIVC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, TIVC has more shares outstanding
The number of shares outstanding for TIVC has been increased compared to 5 years ago.
There is no outstanding debt for TIVC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
TIVC Yearly Shares OutstandingTIVC Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100K 200K 300K 400K 500K
TIVC Yearly Total Debt VS Total AssetsTIVC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

TIVC has an Altman-Z score of -18.56. This is a bad value and indicates that TIVC is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -18.56, TIVC is doing worse than 87.70% of the companies in the same industry.
TIVC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -18.56
ROIC/WACCN/A
WACC8.93%
TIVC Yearly LT Debt VS Equity VS FCFTIVC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

A Current Ratio of 1.70 indicates that TIVC should not have too much problems paying its short term obligations.
TIVC has a worse Current ratio (1.70) than 71.12% of its industry peers.
A Quick Ratio of 1.29 indicates that TIVC should not have too much problems paying its short term obligations.
The Quick ratio of TIVC (1.29) is worse than 66.84% of its industry peers.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.29
TIVC Yearly Current Assets VS Current LiabilitesTIVC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M

More info and screens

2

3. Growth

3.1 Past

TIVC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 88.87%, which is quite impressive.
TIVC shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -33.67%.
The Revenue has been growing by 13.18% on average over the past years. This is quite good.
EPS 1Y (TTM)88.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-33.67%
Revenue growth 3Y-14.77%
Revenue growth 5Y13.18%
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TIVC Yearly Revenue VS EstimatesTIVC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
TIVC Yearly EPS VS EstimatesTIVC Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 -500 -1K -1.5K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TIVC. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TIVC Price Earnings VS Forward Price EarningsTIVC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TIVC Per share dataTIVC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

TIVC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TIVIC HEALTH SYSTEMS INC

NASDAQ:TIVC (8/21/2025, 8:00:02 PM)

After market: 3.32 +0.12 (+3.75%)

3.2

-0.01 (-0.31%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-14 2024-08-14/amc
Earnings (Next)N/A N/A
Inst Owners0%
Inst Owner Change26938.1%
Ins Owners0.09%
Ins Owner Change0%
Market Cap3.46M
Analysts0
Price TargetN/A
Short Float %3.95%
Short Ratio0.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.7
P/FCF N/A
P/OCF N/A
P/B 1.14
P/tB 4.27
EV/EBITDA N/A
EPS(TTM)-15.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.48
BVpS2.81
TBVpS0.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -150.28%
ROE -186.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-177.89%
ROA(5y)-165.61%
ROE(3y)-243.86%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.7
Quick Ratio 1.29
Altman-Z -18.56
F-ScoreN/A
WACC8.93%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)88.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-33.67%
Revenue growth 3Y-14.77%
Revenue growth 5Y13.18%
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y32.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y33.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y32.73%
OCF growth 3YN/A
OCF growth 5YN/A